Andrew Penn is a psychiatric nurse practitioner and associate clinical professor, community health systems, in the School of Nursing at the University of California San Francisco (UCSF). Penn works on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) lab at UCSF. He also practices at the San Francisco Veterans Administration. A leading voice in nursing, Penn is a co-founder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy. He has lectured to audiences as diverse as Oxford University and SXSW and has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, and The Journal of Humanistic Psychotherapy.
Previously
Once the domain of bohemian culture, psychedelics are now headed into mainstream medicine. As psychedelic therapy becomes easier to study, mounting evidence is informing new c...